Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT06589440 |
| Title | Phase 2 Study of SR-8541A in Combination with Botensilimab and Balstilimab in Subjects with Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC) |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | Yes |
| Sponsors | Stingray Therapeutics |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Atlantic Health | RECRUITING | Morristown | New Jersey | 07960 | United States | Details |
| Texas Oncology- Austin | NOT_YET_RECRUITING | Austin | Texas | 78745 | United States | Details |
| Texas Oncology- Sammons- DFW | RECRUITING | Dallas | Texas | 75246 | United States | Details |
| Texas Oncology- Northeast Texas | NOT_YET_RECRUITING | Tyler | Texas | 75702 | United States | Details |
| Swedish | NOT_YET_RECRUITING | Seattle | Washington | 98104 | United States | Details |